연구동향 분석

METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner

Pan Xiaoping Hong Xiaolv Li Sumei Meng Ping Xiao Feng 2021년

논문상세정보
    • 저자 Pan Xiaoping Hong Xiaolv Li Sumei Meng Ping Xiao Feng
    • 제어번호 107391937
    • 학술지명 Experimental and molecular medicine
    • 권호사항 Vol. 53 No. - [ 2021 ]
    • 발행처 생화학분자생물학회
    • 자료유형 학술저널
    • 수록면 1-12
    • 언어 English
    • 출판년도 2021
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner' 의 참고문헌

  • microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2
    Zeng, H. [2018]
  • miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1
    Yi, D. [2019]
  • miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells
    Wang, Y. [2016]
  • miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer
    Li, Y. [2014]
  • miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer
    Zong, Y. [2019]
  • miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells
  • miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer
    Ning, T. [2017]
  • m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
    Jin, D. [2019]
  • Update on the regulation of HIPK1, HIPK2 and HIPK3 protein kinases by microRNAs
    Conte, A. [2018]
  • The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues
    Yao, Q. [2011]
  • The role of oncomirs in the pathogenesis and treatment of breast cancer
  • The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines
    Ergun, S. [2015]
  • Role of ABC-cassette transporters(MDR1, MRP1, BCRP)in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
  • Prognostic and biological significance of microRNA-221 in breast cancer
    Eissa, S. [2015]
  • Predicting and overcoming chemotherapeutic resistance in breast cancer
    Chun, K. H. [2017]
  • Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy
    Zhao, R. [2011]
  • Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor
    Kai, W. [2018]
  • N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
    Wang, H. [2020]
  • N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
    Jin, H. [2019]
  • N(6)-methyladenosine mediates the cellular proliferation and apoptosis via microRNAs in arsenite-transformed cells
    Gu, S. [2018]
  • MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
    Shen, H. [2017]
  • METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
    Han, J. [2019]
  • HIPK2 sustains apoptotic response by phosphorylating Che1/AATF and promoting its degradation
  • HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
    Nodale, C. [2012]
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray F [2018]
  • Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma
    Wang, J. [2011]
  • Doxorubicin-loaded nanoparticles : new advances in breast cancer therapy
    Prados, J. [2012]
  • Discovering Che-1/AATF : a new attractive target for cancer therapy
    Iezzi, S. [2015]
  • Cross-roads to drug resistance and metastasis in breast cancer : miRNAs regulatory function and biomarker capability
  • Co-expression of HIF1alpha, MDR1 and LAPTM4B in peripheral blood of solid tumors
    Rehman, Z. [2019]
  • Classification, treatment strategy, and associated drug resistance in breast cancer
    Tang, Y. [2016]
  • Che-1 activates XIAP expression in response to DNA damage
    Bruno, T. [2008]
  • Autophagy and doxorubicin resistance in cancer
    Chen, C. [2018]
  • Apoptosis-antagonizing transcription factor(AATF)gene silencing : role in induction of apoptosis and down-regulation of estrogen receptor in breast cancer cells
    Sharma, M. [2013]
  • Analysis of miRNA-221 expression level in tumors and marginal biopsies from patients with breast cancer(cross-sectional observational study)
    Abak, A. [2018]
  • 4-Hydroxybenzoic acid(4-HBA)enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway
    Wang, X. N. [2018]